Anetta Undas (A Undas)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 22

Top Topics

Atrial Fibrillation

Pulmonary Embolism

Inferior Vena Cava

Acute Ischemic Stroke

Top Venues

Journal of thrombosis and thrombolysis

Journal of cardiovascular pharmacology

Thrombosis and haemostasis

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Karol Nowak, Michal Zabczyk, Joanna Natorska, Jaroslaw Zalewski, Anetta Undas
Elevated plasma protein carbonylation increases the risk of ischemic cerebrovascular events in patients with atrial fibrillation: association with a prothrombotic state. Journal of thrombosis and thrombolysis (2024)
Marcin Sadowski, Michał Ząbczyk, Anetta Undas
Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide. Journal of thrombosis and thrombolysis 57 (5) (2024)
Marcin Sadowski, Michał Ząbczyk, Anetta Undas
Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide. Journal of thrombosis and thrombolysis 57 (5) (2024)
Martyna Sikorska, Jakub Chmiel, Elzbieta Papuga-Szela, Elzbieta Broniatowska, Anetta Undas
Apixaban Versus Vitamin K Antagonists in Patients With Antiphospholipid Syndrome: A Cohort Study. Journal of cardiovascular pharmacology 84 (1) (2024)
Marcin Sadowski, Michał Ząbczyk, Anetta Undas
Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide. Journal of thrombosis and thrombolysis 57 (5) (2024)
Martyna Sikorska, Jakub Chmiel, Elzbieta Papuga-Szela, Elzbieta Broniatowska, Anetta Undas
Apixaban Versus Vitamin K Antagonists in Patients With Antiphospholipid Syndrome: A Cohort Study. Journal of cardiovascular pharmacology 84 (1) (2024)
Marcin Sadowski, Michał Ząbczyk, Anetta Undas
Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide. Journal of thrombosis and thrombolysis (2024)
Michał Ząbczyk, Joanna Natorska, Paweł T Matusik, Patrycja Mołek, Wiktoria Wojciechowska, Marek Rajzer, Renata Rajtar-Salwa, Tomasz Tokarek, Aleksandra Lenart-Migdalska, Maria Olszowska, Anetta Undas
Neutrophil-activating Peptide 2 as a Novel Modulator of Fibrin Clot Properties in Patients with Atrial Fibrillation. Translational stroke research (2023)
Michał Błaż, Joanna Natorska, Jan Paweł Bembenek, Anna Członkowska, Michał Tomasz Ząbczyk, Maciej Polak, Anetta Undas
Protein Carbonylation Contributes to Prothrombotic Fibrin Clot Phenotype in Acute Ischemic Stroke: Clinical Associations. Stroke (2023)
Bogumił Ramotowski, Anetta Undas, Andrzej Budaj
Altered platelet reactivity, coagulation, endothelial and inflammatory markers early after smoking cessation verified with cotinine plasma concentration. Journal of thrombosis and thrombolysis (2023)
Elżbieta Paszek, Maciej Polak, Anetta Undas
Elevated factor XI is associated with increased risk of recurrent cerebral venous sinus thrombosis: a cohort study. Journal of thrombosis and thrombolysis 57 (3) (2023)
Elżbieta Paszek, Maciej Polak, Anetta Undas
Elevated factor XI is associated with increased risk of recurrent cerebral venous sinus thrombosis: a cohort study. Journal of thrombosis and thrombolysis 57 (3) (2023)
Anetta Undas
The Bleeding Time Test in 2024: A Glorious Past and Current Challenges. Seminars in thrombosis and hemostasis (2023)
Konrad Stępień, Michał Ząbczyk, Magdalena Kopytek, Joanna Natorska, Jarosław Zalewski, Anetta Undas
Reduced fibrin clot permeability on admission and elevated E-selectin at 3 months as novel risk factors of residual pulmonary vascular obstruction in patients with acute pulmonary embolism. Journal of thrombosis and thrombolysis (2023)
Patrycja Mołek, Michał Tomasz Ząbczyk, Krzysztof P Malinowski, Joanna Natorska, Anetta Undas
Enhanced neutrophil extracellular traps formation in AF patients with dilated left atrium. European journal of clinical investigation (2023)
Elżbieta Paszek, Maciej Polak, Anetta Undas
Elevated factor XI is associated with increased risk of recurrent cerebral venous sinus thrombosis: a cohort study. Journal of thrombosis and thrombolysis (2023)
Elżbieta Paszek, Maciej Polak, Anetta Undas
Elevated factor XI is associated with increased risk of recurrent cerebral venous sinus thrombosis: a cohort study. Journal of thrombosis and thrombolysis 57 (3) (2023)
Michał Tomasz Ząbczyk, Maksymilian Hanarz, Krzysztof P Malinowski, Elżbieta Pociask, Saulius Butenas, Grzegorz Gajos, Anetta Undas
Active FXI Can Independently Predict Ischemic Stroke in Anticoagulated Atrial Fibrillation Patients: A Cohort Study. Thrombosis and haemostasis 122 (8) (2022)
Joanna Zuk, Elzbieta Papuga-Szela, Lech Zareba, Anetta Undas
Direct oral anticoagulants in patients with severe inherited thrombophilia: a single-center cohort study. International journal of hematology 113 (2) (2020)
Konstanty Szułdrzyński, Miłosz Jankowski, Daniel P Potaczek, Anetta Undas
Plasma Fibrin Clot Properties as Determinants of Bleeding Time in Human Subjects: Association with Histidine-Rich Glycoprotein. Disease markers 2020 (2020)
Maciej Wiktor Polak, Jakub Siudut, Krzysztof Plens, Anetta Undas
Prothrombotic clot properties can predict venous ulcers in patients following deep vein thrombosis: a cohort study. Journal of thrombosis and thrombolysis 48 (4) (2020)
K Malec, E Broniatowska, Anetta Undas
Direct oral anticoagulants in patients with antiphospholipid syndrome: a cohort study. Lupus 29 (1) (2019)